Paper82604
Mechanism of action of factor D of the alternative complement pathway.
Lesavre PH and 1 other. J Exp Med, 1978. Cited by 191 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Mechanism of action of factor D of the alternative complement pathway. Papers, record 82604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/82604
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Activating Enzymes | Major topic |
| Complement Activation | Major topic |
| Complement Factor D | Major topic |
| Complement Pathway, Alternative | Major topic |
| Complement C3 | |
| Epitopes | |
| Humans | |
| Magnesium | |
| Thrombin |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,059,108 | Properdin: initiation of alternative complement pathway. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1059108 | PubMed |
| 2 | 1,165,475 | Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor. | J Exp Med | 1975 | https://conductscience.org/library/papers/1165475 | PubMed |
| 3 | 1,249,423 | Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF). | J Immunol | 1976 | https://conductscience.org/library/papers/1249423 | PubMed |
| 4 | 12,625 | Purification and some properties of factor D of the human properdin system. | Z Immunitatsforsch Immunobiol | 1976 | https://conductscience.org/library/papers/12625 | PubMed |
| 5 | 126,576 | Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. | Z Immunitatsforsch Exp Klin Immunol | 1975 | https://conductscience.org/library/papers/126576 | PubMed |
| 7 | 138,064 | Plasminogen and plasmin. | Methods Enzymol | 1976 | https://conductscience.org/library/papers/138064 | PubMed |
| 8 | 14,253,466 | FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN. | J Biol Chem | 1965 | https://conductscience.org/library/papers/14253466 | PubMed |
| 9 | 14,316,946 | ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. | J Exp Med | 1965 | https://conductscience.org/library/papers/14316946 | PubMed |
| 10 | 273,923 | Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/273923 | PubMed |
| 11 | 276,881 | Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/276881 | PubMed |
| 12 | 279,011 | Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/279011 | PubMed |
| 13 | 4,105,810 | The C3-activator system: an alternate pathway of complement activation. | J Exp Med | 1971 | https://conductscience.org/library/papers/4105810 | PubMed |
| 14 | 4,111,773 | C3 proactivator convertase and its mode of action. | J Exp Med | 1972 | https://conductscience.org/library/papers/4111773 | PubMed |
| 15 | 4,160,044 | A method of trace iodination of proteins for immunologic studies. | Int Arch Allergy Appl Immunol | 1966 | https://conductscience.org/library/papers/4160044 | PubMed |
| 16 | 4,211,020 | Properdin factor D. II. Activation to D by properdin. | J Exp Med | 1974 | https://conductscience.org/library/papers/4211020 | PubMed |
| 17 | 4,279,261 | Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes. | J Immunol | 1974 | https://conductscience.org/library/papers/4279261 | PubMed |
| 18 | 4,360,349 | Protein iodination with solid state lactoperoxidase. | Biochemistry | 1974 | https://conductscience.org/library/papers/4360349 | PubMed |
| 19 | 4,459,260 | Factor D in the alternate pathway of complement activation: purification, physicochemical characterization and functional role. | Immunochemistry | 1974 | https://conductscience.org/library/papers/4459260 | PubMed |
| 20 | 4,680,711 | Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. | Methods Enzymol | 1972 | https://conductscience.org/library/papers/4680711 | PubMed |
| 21 | 4,733,239 | The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. | Biochem J | 1973 | https://conductscience.org/library/papers/4733239 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,519,165 | Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40519165 | PubMed |
| 40,309,771 | Chronic kidney disease enhances alternative pathway activity: a new paradigm. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40309771 | PubMed |
| 39,914,456 | Granzyme K activates the entire complement cascade. | Nature | 2025 | https://conductscience.org/library/papers/39914456 | PubMed |
| 39,906,134 | Dynamic Complement Protein Changes in Aqueous Humor and Plasma of Patients With Retinal Vein Occlusion During Ranibizumab Treatment. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/39906134 | PubMed |
| 39,865,974 | Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1-5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy. | Immunohorizons | 2025 | https://conductscience.org/library/papers/39865974 | PubMed |
| 39,239,051 | Complement protein expression changes in various conditions of breast cancer: in-silico analyses-experimental research. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39239051 | PubMed |
| 38,541,105 | Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38541105 | PubMed |
| 38,114,042 | Adipsin in the pathogenesis of cardiovascular diseases. | Vascul Pharmacol | 2024 | https://conductscience.org/library/papers/38114042 | PubMed |
| 37,283,768 | Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D. | Front Immunol | 2023 | https://conductscience.org/library/papers/37283768 | PubMed |
| 37,180,495 | A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going? | Ther Adv Rare Dis | 2020 | https://conductscience.org/library/papers/37180495 | PubMed |
| 36,615,677 | Exercise Promotes Bone Marrow Microenvironment by Inhibiting Adipsin in Diet-Induced Male Obese Mice. | Nutrients | 2022 | https://conductscience.org/library/papers/36615677 | PubMed |
| 36,398,537 | Protein therapeutics and their lessons: Expect the unexpected when inhibiting the multi-protein cascade of the complement system. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36398537 | PubMed |
| 36,217,774 | Low-molecular weight inhibitors of the alternative complement pathway. | Immunol Rev | 2023 | https://conductscience.org/library/papers/36217774 | PubMed |
| 35,874,789 | Proprotein Convertases and the Complement System. | Front Immunol | 2022 | https://conductscience.org/library/papers/35874789 | PubMed |
| 35,047,371 | Progress of clinical therapies for dry age-related macular degeneration. | Int J Ophthalmol | 2022 | https://conductscience.org/library/papers/35047371 | PubMed |
| 34,640,602 | The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640602 | PubMed |
| 34,566,967 | Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway. | Front Immunol | 2021 | https://conductscience.org/library/papers/34566967 | PubMed |
| 33,005,239 | Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. | Diabetol Metab Syndr | 2020 | https://conductscience.org/library/papers/33005239 | PubMed |
| 32,376,801 | C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice. | JCI Insight | 2020 | https://conductscience.org/library/papers/32376801 | PubMed |
| 30,135,690 | Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases. | Front Immunol | 2018 | https://conductscience.org/library/papers/30135690 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CFD | 1,675 | PubTator's text mining | https://conductscience.org/library/genes/1675 | NCBI Gene |
| ERVK-3 | 100,862,689 | PubTator's text mining | https://conductscience.org/library/genes/100862689 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/82604
GET https://conductscience.org/api/papers/v1/82604/references?page=2